RU2261098C2 - Перорально распадающаяся композиция, содержащая миртазапин - Google Patents

Перорально распадающаяся композиция, содержащая миртазапин Download PDF

Info

Publication number
RU2261098C2
RU2261098C2 RU2002112238/15A RU2002112238A RU2261098C2 RU 2261098 C2 RU2261098 C2 RU 2261098C2 RU 2002112238/15 A RU2002112238/15 A RU 2002112238/15A RU 2002112238 A RU2002112238 A RU 2002112238A RU 2261098 C2 RU2261098 C2 RU 2261098C2
Authority
RU
Russia
Prior art keywords
mirtazapine
unit dosage
oral
dosage form
tablets
Prior art date
Application number
RU2002112238/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2002112238A (ru
Inventor
НЕЙС Хенрик ДЕ (NL)
НЕЙС Хенрик ДЕ
Original Assignee
Акцо Нобель Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2261098(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Акцо Нобель Н.В. filed Critical Акцо Нобель Н.В.
Publication of RU2002112238A publication Critical patent/RU2002112238A/ru
Application granted granted Critical
Publication of RU2261098C2 publication Critical patent/RU2261098C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2002112238/15A 1999-10-13 2000-10-09 Перорально распадающаяся композиция, содержащая миртазапин RU2261098C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203338.1 1999-10-13
EP99203338 1999-10-13

Publications (2)

Publication Number Publication Date
RU2002112238A RU2002112238A (ru) 2004-01-10
RU2261098C2 true RU2261098C2 (ru) 2005-09-27

Family

ID=8240737

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002112238/15A RU2261098C2 (ru) 1999-10-13 2000-10-09 Перорально распадающаяся композиция, содержащая миртазапин

Country Status (28)

Country Link
EP (1) EP1223914B1 (cg-RX-API-DMAC10.html)
JP (1) JP5561885B2 (cg-RX-API-DMAC10.html)
KR (1) KR100708560B1 (cg-RX-API-DMAC10.html)
CN (1) CN1173701C (cg-RX-API-DMAC10.html)
AR (1) AR026010A1 (cg-RX-API-DMAC10.html)
AT (1) ATE274899T1 (cg-RX-API-DMAC10.html)
AU (1) AU780379B2 (cg-RX-API-DMAC10.html)
BR (1) BR0014593A (cg-RX-API-DMAC10.html)
CA (1) CA2386547C (cg-RX-API-DMAC10.html)
CO (1) CO5251412A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20021315A3 (cg-RX-API-DMAC10.html)
DE (2) DE1223914T1 (cg-RX-API-DMAC10.html)
ES (1) ES2194618T3 (cg-RX-API-DMAC10.html)
HK (1) HK1046641B (cg-RX-API-DMAC10.html)
HU (1) HUP0203148A3 (cg-RX-API-DMAC10.html)
IL (2) IL148777A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA02003519A (cg-RX-API-DMAC10.html)
NO (1) NO20021730L (cg-RX-API-DMAC10.html)
NZ (1) NZ518165A (cg-RX-API-DMAC10.html)
PE (1) PE20010699A1 (cg-RX-API-DMAC10.html)
PL (1) PL200858B1 (cg-RX-API-DMAC10.html)
PT (1) PT1223914E (cg-RX-API-DMAC10.html)
RU (1) RU2261098C2 (cg-RX-API-DMAC10.html)
SK (1) SK6452002A3 (cg-RX-API-DMAC10.html)
TR (1) TR200200978T2 (cg-RX-API-DMAC10.html)
TW (1) TWI256309B (cg-RX-API-DMAC10.html)
WO (1) WO2001026621A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200202293B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2474190A1 (en) * 2002-02-07 2003-08-14 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
WO2007100775A2 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN101129341B (zh) * 2006-08-22 2011-06-01 上海医药工业研究院 口内崩解组合物及其制备方法
EP2377522B1 (en) 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
CN102993208B (zh) * 2011-11-22 2017-01-18 北京哈三联科技股份有限公司 去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用
TW201722406A (zh) * 2012-03-02 2017-07-01 羅德製藥公司 抗破壞性立即釋出型調製劑類
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
JP6601844B2 (ja) * 2016-12-05 2019-11-06 共和薬品工業株式会社 光安定性に優れたミルタザピン含有医薬製剤
CN111714463B (zh) * 2020-08-14 2022-06-17 华农(肇庆)生物产业技术研究院有限公司 米氮平口服剂及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436252A1 (en) * 1989-12-30 1991-07-10 Akzo Nobel N.V. Pharmaceutical preparation for oral administration in fluid form
EP0737473A1 (en) * 1989-10-02 1996-10-16 Cima Labs, Inc. Effervescent dosage form
RU2107058C1 (ru) * 1992-10-07 1998-03-20 Акцо Нобель Н.В. Способ выделения энантиомеров из рацемической смеси
RU97110083A (ru) * 1996-06-19 1999-05-27 Акцо Нобель Н.В. Комбинация, фармацевтическая композиция, способ лечения, использование и упаковка

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
JP3168695B2 (ja) * 1991-06-14 2001-05-21 三菱化学株式会社 ショ糖脂肪酸エステルの置換度の低下方法
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JPH05163137A (ja) * 1991-12-12 1993-06-29 Shin Etsu Chem Co Ltd 有核顆粒
JPH0737473A (ja) * 1993-07-27 1995-02-07 Murata Mfg Co Ltd 圧力スイッチ
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
JP3870470B2 (ja) * 1997-02-07 2007-01-17 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737473A1 (en) * 1989-10-02 1996-10-16 Cima Labs, Inc. Effervescent dosage form
EP0436252A1 (en) * 1989-12-30 1991-07-10 Akzo Nobel N.V. Pharmaceutical preparation for oral administration in fluid form
RU2107058C1 (ru) * 1992-10-07 1998-03-20 Акцо Нобель Н.В. Способ выделения энантиомеров из рацемической смеси
RU97110083A (ru) * 1996-06-19 1999-05-27 Акцо Нобель Н.В. Комбинация, фармацевтическая композиция, способ лечения, использование и упаковка

Also Published As

Publication number Publication date
DE60013466T2 (de) 2005-01-20
ES2194618T1 (es) 2003-12-01
NZ518165A (en) 2004-03-26
JP2003511403A (ja) 2003-03-25
CO5251412A1 (es) 2003-02-28
AU1023201A (en) 2001-04-23
IL148777A0 (en) 2002-09-12
ES2194618T3 (es) 2005-04-01
EP1223914A2 (en) 2002-07-24
CN1378452A (zh) 2002-11-06
KR100708560B1 (ko) 2007-04-19
HK1046641B (en) 2005-04-08
PT1223914E (pt) 2004-11-30
SK6452002A3 (en) 2002-09-10
TWI256309B (en) 2006-06-11
PL200858B1 (pl) 2009-02-27
PL354584A1 (en) 2004-01-26
IL148777A (en) 2013-10-31
WO2001026621A3 (en) 2001-10-11
DE60013466D1 (de) 2004-10-07
WO2001026621A2 (en) 2001-04-19
HUP0203148A3 (en) 2004-06-28
ZA200202293B (en) 2003-06-20
AR026010A1 (es) 2002-12-26
NO20021730L (no) 2002-05-30
ATE274899T1 (de) 2004-09-15
MXPA02003519A (es) 2002-08-20
KR20020038946A (ko) 2002-05-24
BR0014593A (pt) 2002-06-11
CA2386547A1 (en) 2001-04-19
EP1223914B1 (en) 2004-09-01
NO20021730D0 (no) 2002-04-12
PE20010699A1 (es) 2001-07-06
DE1223914T1 (de) 2003-09-18
HUP0203148A2 (hu) 2003-01-28
CZ20021315A3 (cs) 2002-07-17
HK1046641A1 (en) 2003-01-24
JP5561885B2 (ja) 2014-07-30
RU2002112238A (ru) 2004-01-10
TR200200978T2 (tr) 2002-09-23
AU780379B2 (en) 2005-03-17
CN1173701C (zh) 2004-11-03
CA2386547C (en) 2010-06-08

Similar Documents

Publication Publication Date Title
KR101020809B1 (ko) 펙소페나딘을 함유하는 구강 분산성 정제
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
US6376550B1 (en) Pharmaceutical compositions containing tramadol for migraine
RU2314810C2 (ru) Способ лечения с использованием лекарственных форм, содержащих фармацевтические композиции 5,8,14-триазатетрацикло[10.3.1.0 (2,11).0(4,9)] гексадека-2( 11),3,5,7,9-пентаена
RU2001111887A (ru) Композиция в виде множества частиц с модифицированным высвобождением
EP0804172B1 (en) Controlled release potassium dosage form
AU3925399A (en) Solid, quick dissolving cetirizine formulations
US20060263427A1 (en) Quinine formulations
CA2386547C (en) Orally disintegrating composition comprising mirtazapine
NZ506020A (en) Use of pharmaceutical combinations containing tramadol and an antiemetic
ZA200600159B (en) Novel solid pharmaceutical composition comprising amisulpride
BRPI0615989B1 (pt) Formulação farmacêutica de dosagem oral
JP3170855B2 (ja) イブプロフェン含有解熱鎮痛剤
US6008222A (en) Method for oral administration of buspirone and nefazodone
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
US7838029B1 (en) Mirtazapine solid dosage forms
NZ207768A (en) Sustained release tablets comprising dipyridamole
CZ79593A3 (en) Antitussive preparation
JP2019515045A (ja) 甲状腺ホルモン又はそのアナログを提供する組成物及び方法
RU2386439C2 (ru) Фармацевтическая комбинация, включающая винпоцетин и бетагистин, для лечения недостаточности кровообращения мозга
RU2270010C2 (ru) Фармацевтическая композиция, обладающая снотворным действием
JP2006509789A (ja) 不安症治療法及び治療薬
US20100273844A1 (en) Pharmaceutical compositions for treating or preventing migaines
JPH09136843A (ja) 血圧上昇薬

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20070411

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20120326

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20130917

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20140402